Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors
This cohort study describes the morphologic classification, histopathologic characteristics, treatments, and outcomes of chronic cutaneous immune-related adverse events occurring in adjuvant or metastatic setting.
Authors
- Asha Tipirneni
- Ryan J. Sullivan (ORCID: https://orcid.org/0000-0001-5344-6645)
- Anna K. Dewan (ORCID: https://orcid.org/0000-0001-5777-2878)
- Kylie Fletcher (ORCID: https://orcid.org/0000-0003-0723-9236)
- Douglas Buckner Johnson (ORCID: https://orcid.org/0000-0002-6390-773X)
- James R. Patrinely (ORCID: https://orcid.org/0000-0002-0979-1625)
- Suthee Rapisuwon (ORCID: https://orcid.org/0000-0002-1389-925X)
- Rachel Woodford (ORCID: https://orcid.org/0000-0002-9470-314X)
- Faisal Fa’ak (ORCID: https://orcid.org/0000-0002-9034-4100)
- Hui‐Ling Yeoh (ORCID: https://orcid.org/0000-0003-3836-5251)
- Georgina Venetia Long (ORCID: https://orcid.org/0000-0001-8894-3545)
- Iman Osman (ORCID: https://orcid.org/0000-0002-1472-1971)
- Matteo Salvatore Carlino (ORCID: https://orcid.org/0000-0002-7861-4104)
- Aleigha Lawless (ORCID: https://orcid.org/0009-0009-3861-3164)
- Andrew Haydon (ORCID: https://orcid.org/0000-0002-4631-5855)
- Janice M. Mehnert (ORCID: https://orcid.org/0000-0001-9492-9264)
- Rachel Goodman (ORCID: https://orcid.org/0000-0001-7992-8108)
- Alexander M. Menzies
Institutions
- The University of Sydney (AU)
- Harvard University (US)
- Georgetown University (US)
- Vanderbilt University (US)
- Georgetown University Medical Center (US)
- Royal North Shore Hospital (AU)
- Westmead Hospital (AU)
- NYU Langone Health (US)
- Massachusetts General Hospital (US)
- Melanoma Institute Australia (AU)
- Alfred Health (AU)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1001/jamadermatol.2025.0025
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09